2017
$200M
from 12 investors over 12 rounds
NiKang Therapeutics Inc. raised $200M on May 26, 2021
Investors: Wellington Management, Surveyor Capital, Samsara BioCapital, Perceptive Advisors, RTW Investments, LP, RA Capital Management, L.P., 经纬创投(北京)投资管理顾问有限公司, Octagon Capital Advisors and Partner Fund Management
NiKang Therapeutics Inc. raised $50M on September 14, 2020
Investors: Lilly Asia Ventures, Casdin Capital, LLC and RTW Investments, LP